A recent clinical trial, published in the New England Journal of Medicine, tested whether a GLP-1 agonist called lixisenatide could be a new treatment approach for people in the early stages of Parkinson's
Notice that at 5 mg/mL, reaching even the standard starting dose of 2.5 mg requires drawing 50 units, which is half a milliliter
Increase Fiber Gradually: Fiber is the food for your probiotics (known as prebiotics)
Global obesity spending reached nearly $24bn in 2023, an over sevenfold growth in value in just three years, driven by the advent of new agents, and from 2024 onwards the market is forecasted to accelerate rapidly, with a possible 24-27% CAGR to 2028, and a potential value of up to $131bn by 2028, according to the IQVIA Institutes Global Use of Medicines 2024 report 4
Semaglutide affects body composition in ways that the scale cannot capture
If your main goal is the highest average weight loss seen in large studies, GLP-1based medications lead the category, with semaglutide showing about 14.9% average loss at 68 weeks and tirzepatide showing up to about 20.9% at 72 weeks (dose-dependent)